Picture Kentro Design Corporate and Web Design Berlin 650x65px
Document › Details

Zavante Therapeutics, Inc.. (10/9/15). "Press Release: Zavante Announces New Company Formation and Initial Financing". San Diego, CA.

Region Region San Diego, CA
  Country United States (USA)
Organisation Organisation Zavante Therapeutics Inc.
  Group Nabriva (Group)
Products Product Contepo™ (fosfomycin for injection, previously ZTI-01 and ZOLYD)
  Product 2 venture capital
Person Person Schroeder, Ted (Nabriva 201807– CEO before Zavante Therapeutics + Cadence Pharmaceuticals + Élan)

Zavante Therapeutics, Inc., announced today the formation of a newly formed, clinical late-stage biopharmaceutical company focused on developing novel therapies to improve the outcomes of hospitalized patients. The lead product candidate, ZTI-01, is a novel injectable antibiotic with a broad spectrum of bactericidal Gram-negative and Gram-positive activity, including activity against most contemporary MDR strains where current therapeutic choices are severely limited. Zavante’s strategic intent is to develop ZTI-01 for multiple MDR infection types. Management believes that ZTI-01 will qualify for government programs designed to assist drug developers in bringing new infectious disease product candidates to the market.

The company will be based in San Diego, California. The company previously closed an initial private round of financing.

Biotech veteran Cam Garner has been appointed Chairman and Ted Schroeder, former CEO of Cadence Pharmaceuticals, has been appointed Chief Executive Officer and a Director.

Rounding out the initial management team is Kevin Finney, former Head of Allergan Corporate Development, appointed Chief Operations Officer, Evelyn (EJ) Ellis-Grosse, Ph.D appointed Chief Scientific Officer, Cam Gallagher appointed Chief Business Officer, Jim Breitmeyer, M.D., Ph.D has joined the group as Acting Chief Medical Officer and Krissy Haeckl as Acting VP of Regulatory.

Record changed: 2018-08-03


Picture [LSE] – The Business Web Portal 650x65px

More documents for Nabriva (Group)

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at (European life sciences) and (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at (life sciences in German-speaking Europe) and (worldwide mass spectrometry)


Picture ConsulTech GmbH GDPR-compliant E-Col Home Office 650x80px

» top